Preview Mode Links will not work in preview mode

Jan 31, 2025

Featuring an interview with Dr Seth Wander, including the following topics:

  • The clinical utility of ESR1 mutations in HR-positive, HER2-negative advanced breast cancer
    • Grinshpun A et al. The clinical utility of ESR1 mutations in hormone receptor-positive, HER2-negative advanced breast cancer. Hematol Oncol Clin...


Jan 30, 2025

Featuring perspectives from Dr Jennifer Woyach, including the following topics:

  • AMPLIFY — First-Line Trials Combining Bruton Tyrosine Kinase (BTK) Inhibitors with Venetoclax
    • Introduction (0:00)
    • Case: An African American man in his mid 40s with progressive lymphadenopathy in the neck is diagnosed with chronic...


Jan 24, 2025

Featuring perspectives from Dr Lisa Carey and Dr Rita Nanda, including the following topics:

  • Introduction (0:00)
  • Patient Videos and Clinical Investigator Survey (3:26)
  • San Antonio Breast Cancer Symposium (SABCS®) Report — Education Session on Antibody-Drug Conjugates (26:03)
  • Patient Videos and Clinical...


Jan 17, 2025

Featuring perspectives from Dr Lisa A Carey and Dr Rita Nanda, including the following topics: 

  • Introduction (0:00)
  • Stages of Triple-Negative Breast Cancer (TNBC); Recurrence After Adjuvant Treatment (5:28)
  • Long-Term Outcomes with Metastatic TNBC (11:55)
  • Side Effects and Complications of Treatment (24:42)
  • Dose...


Jan 16, 2025

Featuring perspectives from Dr Jeremy S Abramson, Dr Jennifer Crombie, Prof Martin Hutchings, Dr Matthew Lunning and Dr Tycel Phillips, moderated by Dr Abramson, including the following topics:

  • Introduction (0:00)
  • Chimeric Antigen Receptor (CAR) T-Cell Therapy for Diffuse Large B-Cell Lymphoma (DLBCL) — Dr...